Drug Profile


Alternative Names: RO 466240

Latest Information Update: 17 Nov 2006

Price : $50

At a glance

  • Originator Roche
  • Class Antithrombotics; Naphthalenes; Piperidines; Small molecules
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial infarction; Thrombosis

Most Recent Events

  • 08 Jun 1999 A clinical study has been added to the Thromboses pharmacodynamics section
  • 28 Oct 1997 A study has been added to the Ischaemic Heart Disease and Thromboses pharmacodynamics sections
  • 28 Oct 1997 A study has been added to the Thromboses therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top